Technetium-99m-Tetrofosmin for Parathyroid Scintigraphy: Comparison to Thallium-Technetium Scanning

• Published in: The Journal of nuclear medicine (1978) Vol. 39; no. 8; pp. 1433 - 1441
• Main Authors: Apostolopoulos, Dimitris J, Houstoulaki, Evangelia, Giannakenas, Costas, Alexandrides, Theodore, Spiliotis, John, Nikiforidis, George, Vlachojannis, John G, Vassilakos, Pavlos J
• Format: Journal Article
• Language: English
• Published: Reston, VA Soc Nuclear Med 01.08.1998; Society of Nuclear Medicine
• Subjects: Adenoma - diagnostic imaging; Biological and medical sciences; Endocrinopathies; Female; Humans; Hyperparathyroidism, Secondary - diagnostic imaging; Hyperplasia - diagnostic imaging; Male; Medical sciences; Middle Aged; Non tumoral diseases. Target tissue resistance. Benign neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Parathyroid Glands - diagnostic imaging; Parathyroid Glands - pathology; Parathyroid Neoplasms - diagnostic imaging; Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases); Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m; Subtraction Technique; Thallium Radioisotopes; Thyroid Gland - diagnostic imaging; Time Factors; Endocrinopathy; Radionuclide study; Human; Thallium; Sensitivity analysis; Tetrofosmin; Technetium; Scintigraphy; Specificity; Parathyroid diseases; Efficiency; Distribution; Medical imagery; Diagnosis; Radiopharmaceuticals; Comparative study; Hyperparathyroidism
• ISSN: 0161-5505; 1535-5667

The efficacy of 99mTc-tetrofosmin for the detection of parathyroid lesions was investigated prospectively in patients with hyperparathyroidism referred for surgical treatment. Twenty-seven patients with primary and 18 with tertiary hyperparathyroidism were studied. Twelve patients had undergone one or more previous neck explorations. Static imaging with 201Tl was performed first, immediately followed by a 30-min 99mTc-tetrofosmin dynamic study. Delayed views of up to 3 hr postinjection were also obtained. Technetium-99m-pertechnetate was used for thyroid delineation. The tetrofosmin/99mTc-pertechnetate subtraction scan (TF/TC), the single-tracer washout technique and the thallium/technetium subtraction (TL/TC) were compared. Quantification of relative uptakes of tracers in the thyroid and abnormal parathyroids was accomplished by measuring activity within regions of interest. Kinetics of tetrofosmin in the thyroid and abnormal parathyroids were studied by evaluating the plots of the parathyroid to thyroid ratios against time as well as by calculation of the half-clearance times from the slow component of the time-activity curves. The overall sensitivity, specificity and accuracy of TF/TC and TL/TC were 76%, 92% and 83% and 52%, 85% and 65%, respectively. The respective sensitivities were 87% and 70% for adenomas and 72% and 46% for hyperplasia. The parathyroid-to-thyroid activity ratios of tetrofosmin were significantly higher than those of thallium (p < 0.001). The tetrofosmin single-tracer washout study was less accurate than the subtraction technique (overall sensitivity and specificity, 70% and 69%, respectively). The washout properties of tetrofosmin in abnormal parathyroids were not substantially different from those in the thyroid, with a few exceptions (p = 0.4). No correlation of half-clearance times with parathyroid size, degree of early uptake, parathyroid hormone levels or histology could be established. Comparing adenomas to hyperplasia in respect to tetrofosmin retention, a statistically significant difference was observed (p = 0.005). Technetium-99m-tetrofosmin is suitable for parathyroid imaging. The kinetic properties of this agent in parathyroid and thyroid tissues do not warrant differential washout protocols. The diagnostic impact of the observed difference in tetrofosmin kinetics between parathyroid adenomas and hyperplasia requires further investigation.